|
1
|
Perry VH, Nicoll JA and Holmes C:
Microglia in neurodegenerative disease. Nat Rev Neurol. 6:193–201.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Block ML, Zecca L and Hong JS:
Microglia-mediated neurotoxicity: Uncovering the molecular
mechanisms. Nature Rev Neurosci. 8:57–69. 2007. View Article : Google Scholar
|
|
3
|
Liu B and Hong JS: Role of microglia in
inflammation-mediated neurodegenerative disease: Mechanisms and
strategies for therapeutic intervention. J Pharmacol Exp Ther.
304:1–7. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hanisch Uk and Kettenmann H: Microglia:
Active sensor and versatile effector cells in the normal and
pathologic brain. Nat Neurosci. 10:1387–1394. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gehrmann J, Matsumoto Y and Kreutzberg GW:
Microglia: Intrinsic immuneffector cell of the brain. Brain Res
Rev. 20:269–287. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lynch MA: The multifaceted profile of
activated microglia. Mol Neurobiol. 40:139–156. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li YH, Teng P, Wang Y, Zhang YM, Ma CJ and
Pu J: Expression and regulation of HSP60 in activated microglia
cells. J Ningxia Med Univ. 8:712–714. 2011.
|
|
8
|
Zhang D, Sun L, Zhu H, Wang L, Wu W, Xie J
and Gu J: Microglial LOX-1 reacts with extracellular HSP60 to
bridge neuroinflammation and neurotoxicity. Neurochem Int.
61:1021–1035. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheng W, Li Y, Hou X, Zhang N, Ma J, Ding
F, Li F, Miao Z, Zhang Y, Qi Q, et al: HSP60 is involved in the
neuroprotective effects of naloxone. Mol Med Rep. 10:2172–2176.
2014.PubMed/NCBI
|
|
10
|
Zhao P, Zhou R, Zhu XY, Hao YJ, Li N, Wang
J, Niu Y, Sun T, Li YX and Yu JQ: Matrine attenuates focal cerebral
ischemic injury by improving antioxidant activity and inhibiting
apoptosis in mice. Int J Mol Med. 36:633–644. 2015.PubMed/NCBI
|
|
11
|
Rong B, Zhao C, Gao W and Yang S: Matrine
promotes the efficacy and safety of platinum-based doublet
chemotherapy for advanced non-small cell lung cancer. Int J Clin
Exp Med. 8:14701–14717. 2015.PubMed/NCBI
|
|
12
|
Kan QC, Pan QX, Zhang XJ, Chu YJ, Liu N,
Lv P, Zhang GX and Zhu L: Matrine ameliorates experimental
autoimmune encephalomyelitis by modulating chemokines and their
receptors. Exp Mol Pathol. 99:212–219. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kan QC, Lv P, Zhang XJ, Xu YM, Zhang GX
and Zhu L: Matrine protects neuro-axon from CNS
inflammation-induced injury. Exp Mol Pathol. 98:124–130. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang ML, Zhang XJ, Kang J, Zhang HJ, Chen
XL, Liu N, Liu SQ, Ma WD, Zhang GX and Zhu L: Matrine promotes NT3
expression in CNS cells in experimental autoimmune
encephalomyelitis. Neurosci Lett. 649:100–106. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chandra D, Choy G and Tang DG: Cytosolic
accumulation of HSP60 during apoptosis with or without apparent
mitochondrial release: evidence that its pro-apoptotic or
pro-survival functions involve differential interactions with
caspase-3. J Biol Chem. 282:31289–31301. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kreutzberg GW: Microglia: A sensor for
pathological events in the CNS. Trends Neurosci. 19:312–328. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Teng P, Li Y, Cheng W, Zhou L, Shen Y and
Wang Y: Neuroprotective effects Of Lycium barbarum polysaccharides
in lipopolysaccharide-induced BV2 microglia cells. Mol Med Rep.
7:1977–1981. 2013.PubMed/NCBI
|
|
18
|
Miao RM, Fang ZH and Yao Y: Therapeutic
efficacy of tetrandrine tablets combined with matrine injection in
treatment of silicosis. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za
Zhi. 30:778–780. 2012.(In Chinese). PubMed/NCBI
|
|
19
|
Lao Y: Clinical study of matrine injection
on preventing liver function damage of anti-tumor drugs during
chemotherapy of breast cancer. Zhong Yao Cai. 28:735–737. 2005.(In
Chinese). PubMed/NCBI
|
|
20
|
Quintana FJ and Cohen IR: HSP60 speaks to
the immune system in many voices. Novartis Found symp. 291:101–114.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lehnardt S, Schott E, Trimbuch T, Laubisch
D, Krueger C, Wulczyn G, Nitsch R and Werber JR: A vicious cycle
involving release of heat shock protein 60 from injured cells and
activation of toll-like receptor 4 mediates neurodegeneration in
the CNS. J Neurosci. 28:2320–2331. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hansen JJ, Bross P, Westergaard M, Nielsen
MN, Eiberg H, Børglum AD, Mogensen J, Kristiansen K, Bolund L and
Gregersen N: Genomic structure of the human mitochondrial
chaperonin genes: HSP60 and HSP10 are localised head to head on
chromosome 2 separated by a bidirectional promoter. Hum Genet.
112:71–77. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao Z, Ma J and Yuan WJ: Heat shock
protein 60 in cell apoptosis. Sheng Li Ke Xue Jin Zhan. 39:267–270.
2008.(In Chinese). PubMed/NCBI
|
|
24
|
Gupta S and Knowlton AA: HSP60 trafficking
in adult cardiac myocytes: Role of the exosomal pathway. Am J
Physiol Heart Circ Physiol. 292:H3052–H3056. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Burguillos MA, Deierborg T, Kavanagh E,
Persson A, Hajji N, Garcia-Quintanilla A, Cano J, Brundin P,
Englund E, Venero JL and Joseph B: Caspase signalling controls
microglia activation and neurotoxicity. Nature. 472:319–324. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Samali A, Cai J, Zhivotovsky B, Jones DP
and Orrenius S: Presence of a pre-apoptotic complex of
pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of
jurkat cells. EMBO J. 18:2040–2048. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Chen L, Hagiwara N and Knowlton
AA: Regulation of heat shock protein 60 and 72 expression in the
failing heart. J Mol Cell Cardiol. 48:360–366. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rosenberger K, Dembny P, Derkow K, Engel
O, Krüger C, Wolf SA, Kettenmann H, Schott E, Meisel A and Lehnardt
S: Intrathecal heat shock protein 60 mediates neurodegeneration and
demyelination in the CNS through a TLR-4 and MyD88-dependent
pathway. Mol Neurodegener. 10:52015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Montgomery SL and Bowers WJ: Tumor
necrosis factor-alpha and the roles it plays in homeostatic and
degenerative processes within the central nervous system. J
Neuroimmune Pharmacol. 7:42–59. 2012. View Article : Google Scholar : PubMed/NCBI
|
